Y-MABS THERAPEUTICS INC. - COMMON STOCK
12.37
14-نوفمبر-24 12:13:23
15 متأخرة بدقائق
الأسهم
-0.82
-6.18%
نطاق اليوم
11.50 - 12.97
ISIN
N/A
المصدر
NASDAQ
-
Y-mAbs Reports Fourth Quarter and Full-Year 2022 Financial Results and Recent Corporate Developments
30 مارس 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs to Announce 2022 Financial and Operating Results on March 30, 2023
21 مارس 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
02 فبراير 2023 09:00:00 بحسب Nasdaq GlobeNewswire
-
04 يناير 2023 16:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Therapeutics to Present at 41st Annual J.P. Morgan Healthcare Conference
03 يناير 2023 09:00:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Partnership Regarding Early Access Program for DANYELZA (naxitamab-gqgk) in Europe
21 ديسمبر 2022 09:00:00 بحسب Nasdaq GlobeNewswire
-
16 ديسمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Pipeline Update
14 ديسمبر 2022 09:00:01 بحسب Nasdaq GlobeNewswire
-
Y-mAbs’ DANYELZA® (naxitamab-gqgk) for the Treatment of High-Risk Neuroblastoma Approved in China
08 ديسمبر 2022 09:00:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs to Host Annual Research and Development Day in New York
06 ديسمبر 2022 09:00:01 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Complete Response Letter for Omburtamab Biologics License Application
01 ديسمبر 2022 17:34:16 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
07 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs to Announce Third Quarter 2022 Financial and Operating Results on November 7, 2022
02 نوفمبر 2022 16:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Outcome of FDA Advisory Committee Meeting on Omburtamab
28 أكتوبر 2022 15:33:33 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Pivotal Data for Omburtamab
03 أكتوبر 2022 09:00:01 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Regulatory Filing for DANYELZA® (naxitamab-gqgk) in Brazil
26 سبتمبر 2022 09:00:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Scheduling of FDA Advisory Committee Meeting for Omburtamab
01 سبتمبر 2022 16:05:00 بحسب Nasdaq GlobeNewswire
-
30 أغسطس 2022 09:00:01 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Second Quarter Financial Results and Recent Corporate Developments
08 أغسطس 2022 16:05:02 بحسب Nasdaq GlobeNewswire
-
Y-mAbs to Announce Second Quarter 2022 Financial and Operating Results on August 8, 2022
02 أغسطس 2022 09:00:00 بحسب Nasdaq GlobeNewswire